Screener
Metagenomi Therapeutics, Inc. MGX Q1 2025 earnings
Reported May 13, 2025 · Before market open
Revenue$4.1MMiss by $4.2M
EPS-$0.68Miss by $0.06
Revenue estimate$8.3M
EPS estimate-$0.62
Next report
Nov 10, 2026 (in 2 months)Revenue estimate$2.6M
EPS estimate-$0.64
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Metagenomi Therapeutics, Inc. report Q1 2025 earnings?
- Metagenomi Therapeutics, Inc. (MGX) reported Q1 2025 earnings on May 13, 2025 before market open.
- What were Metagenomi Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Metagenomi Therapeutics, Inc. reported revenue of $4.1M and eps of $-0.68 for Q1 2025.
- Did Metagenomi Therapeutics, Inc. beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $8.3M by $4.2M. EPS missed the consensus estimate of $-0.62 by $0.06.
- How did Metagenomi Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 63.0% from $11.2M a year earlier and eps grew 42.9% from $-1.19.
- Where can I find Metagenomi Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-070448) and the 10-Q periodic report (0000950170-25-070463) directly on SEC EDGAR. The filing index links above go to sec.gov.
